HUTCHMED (China) Ltd Files August 2024 6-K Report
Ticker: HMDCF · Form: 6-K · Filed: Aug 21, 2024 · CIK: 1648257
Sentiment: neutral
Topics: reporting, foreign-private-issuer, disclosure
TL;DR
HUTCHMED filed its August 6-K, confirming 20-F reporting. Standard disclosure.
AI Summary
HUTCHMED (China) Limited filed a Form 6-K on August 21, 2024. This report is for the month of August 2024 and indicates the company files annual reports under Form 20-F. The company's principal executive offices are located in Hong Kong.
Why It Matters
This filing provides routine disclosure for HUTCHMED as a foreign private issuer, informing investors about their reporting status and location.
Risk Assessment
Risk Level: low — This is a routine filing that does not contain new financial or operational information, making the immediate risk low.
Key Players & Entities
- HUTCHMED (China) Limited (company) — Registrant
- August 21, 2024 (date) — Filing Date
- Form 6-K (document) — Filing Type
- Form 20-F (document) — Annual Report Form
- Hong Kong (location) — Principal Executive Offices
FAQ
What is the purpose of a Form 6-K filing?
A Form 6-K is a report of foreign private issuers pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934, used to furnish information to the SEC that the company has made or is required to make public in its home country.
Which annual report form does HUTCHMED (China) Limited file?
HUTCHMED (China) Limited files its annual reports under cover of Form 20-F.
Where are HUTCHMED's principal executive offices located?
HUTCHMED's principal executive offices are located at 48th Floor, Cheung Kong Center, 2 Queen's Road Central, Hong Kong.
What is the filing date of this specific Form 6-K?
The filing date of this Form 6-K is August 21, 2024.
What period does this Form 6-K report cover?
This Form 6-K is for the month of August 2024.
Filing Stats: 163 words · 1 min read · ~1 pages · Grade level 13.2 · Accepted 2024-08-21 06:07:52
Filing Documents
- hcm-20240821x6k.htm (6-K) — 19KB
- hcm-20240821xex99d1.htm (EX-99.1) — 24KB
- hcm-20240821xex99d1001.gif (GRAPHIC) — 4KB
- 0001648257-24-000067.txt ( ) — 49KB
From the Filing
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 6-K REPORT OF FOREIGN PRIVATE ISSUER PURSUANT TO RULE 13a-16 OR 15d-16 UNDER THE SECURITIES EXCHANGE ACT OF 1934 For the Month of August 2024 Commission File Number: 001-37710 HUTCHMED (CHINA) LIMITED (Translation of registrant's name into English) 48th Floor, Cheung Kong Center, 2 Queen's Road Central, Hong Kong (Address of principal executive offices) Indicate by check mark whether the registrant files or will file annual reports under cover of Form 20-F or Form 40-F. Form 20-F Form 40-F HUTCHMED (CHINA) LIMITED Form 6-K EXHIBIT INDEX Exhibit No. Description Exhibit 99.1 Press release relating to HUTCHMED's expert call to discuss immune thrombocytopenia 2 SIGNATURE Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized. HUTCHMED (CHINA) LIMITED By: /s/ Johnny Cheng Name: Johnny Cheng Title: Chief Financial Officer Date: August 21, 2024 3